Publication

March 21, 2023
Effect of Higher-Dose Ivermectin for 6 Days vs Placebo on Time to Sustained Recovery in Outpatients With COVID-19: A Randomized Clinical Trial
JAMA
March 21, 2023
Effect of Thromboprophylaxis on Clinical Outcomes After COVID-19 Hospitalization
Annals of Internal Medicine.
March 21, 2023
Heterogeneous Treatment Effects of Therapeutic-Dose Heparin in Patients Hospitalized for COVID-19
March 1, 2023
Symptom and Viral Rebound in Untreated SARS-CoV-2 Infection
Annals of Internal Medicine
February 18, 2023
Nasal and Plasma Severe Acute Respiratory Syndrome Coronavirus 2 RNA Levels Are Associated With Timing of Symptom Resolution in the ACTIV-2 Trial of Nonhospitalized Adults With Coronavirus Disease 2019
Clinical Infectious Diseases
February 1, 2023
Efficacy and Safety of Ensovibep for Adults Hospitalized With COVID-19
Annals of Internal Medicine
January 31, 2023
Qualitative interviews to evaluate content validity of the ACTIV-2 COVID-19 Symptom Diary (ACSD)
Journal of Patient-Reported Outcomes
January 24, 2023
Effect of Fluvoxamine vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19: A Randomized Clinical Trial
JAMA
January 20, 2023
Phase 2 safety and antiviral activity of SAB-185, a novel polyclonal antibody therapy for non-hospitalized adults with COVID-19
Journal of Infectious Disease
January 19, 2023
Publisher Correction: Antiviral and clinical activity of bamlanivimab in a randomized trial of non-hospitalized adults with COVID-19
Nature Communications
January 1, 2023
Infliximab as a potential treatment for COVID-19
Expert Review of Anti-Infective Therapy
December 22, 2022
Bamlanivimab therapy for acute COVID-19 does not blunt SARS-CoV-2-specific memory T cell responses
JCI Insight
Show More

Donate

Donate to the FNIH today to support medical research that saves lives

Partner With Us

Work with the FNIH to accelerate medical breakthroughs for patients